Vanguard Russell 1000 Growth ETF (VONG)
124.91
+1.94 (1.58%)
NASDAQ· Last Trade: Jul 22nd, 12:47 AM EDT
Detailed Quote
| Previous Close | 122.97 |
|---|---|
| Open | 124.38 |
| Day's Range | 123.93 - 125.06 |
| 52 Week Range | 105.22 - 132.94 |
| Volume | 893,996 |
| Market Cap | - |
| Dividend & Yield | 0.6360 (0.51%) |
| 1 Month Average Volume | 1,371,861 |
Chart
News & Press Releases
Vanguard Russell 1000 Growth ETF (NASDAQ:VONG) has outperformed the market over the past 15 years by 2.57% on an annualized basis producing an average annual return of 14.9%. Currently, Vanguard Russell 1000 Growth ETF
Via Benzinga · July 21, 2026
It went from growth to value. Is that a good thing?
Via The Motley Fool · July 16, 2026
VONG delivers superior 5-year returns and lower drawdowns, while VBK offers higher recent gains with broader diversification across 579 holdings.
Via The Motley Fool · July 14, 2026
The Vanguard Russell 1000 Growth ETF (VONG) may not have the name recognition, but it's got the track record.
Via The Motley Fool · July 8, 2026
SpaceX is already in some indexes.
Via The Motley Fool · July 7, 2026
Compare sector allocations, risk profiles, and long-term growth potential as these two funds target distinct corners of the US equity market.
Via The Motley Fool · July 1, 2026

Vanguard Russell 1000 Growth ETF (NASDAQ:VONG) has outperformed the market over the past 10 years by 3.69% on an annualized basis producing an average annual return of 17.22%. Currently, Vanguard Russell 1000 Growth ETF
Via Benzinga · June 29, 2026
Portfolio concentration and benchmark differences set these two low-cost growth ETFs apart for investors seeking large-cap exposure.
Via The Motley Fool · June 26, 2026
Vanguard Russell 1000 Growth ETF (NASDAQ:VONG) has outperformed the market over the past 10 years by 3.66% on an annualized basis producing an average annual return of 17.44%. Currently, Vanguard Russell 1000 Growth ETF
Via Benzinga · June 23, 2026
Growth stocks have unsurprisingly outperformed the S&P 500. But this growth ETF from Vanguard has done even better.
Via The Motley Fool · June 23, 2026
Compare sector weightings, top holdings, and risk profiles as these two growth ETFs take different paths to capital appreciation.
Via The Motley Fool · June 21, 2026
Compare sector exposure, risk profiles, and income potential as these two growth ETFs take different approaches to capturing U.S. market gains.
Via The Motley Fool · June 20, 2026
It's one of the best-performing Vanguard ETFs.
Via The Motley Fool · June 18, 2026
Portfolio concentration and diversification take center stage as these two funds reveal distinct approaches to capturing U.S. growth stocks.
Via The Motley Fool · June 17, 2026
June is an exciting month for the markets. Here's what could happen.
Via The Motley Fool · June 17, 2026
Compare sector allocations, top holdings, and risk profiles to see how these growth ETFs stack up for different investor goals.
Via The Motley Fool · June 16, 2026
One of the ETFs has averaged annual gains of 16.4% over the past 15 years.
Via The Motley Fool · June 12, 2026
Explore how portfolio size, sector focus, and volatility set these growth ETFs apart for investors seeking different risk profiles and market exposures.
Via The Motley Fool · June 11, 2026
Compare sector weightings, risk profiles, and long-term growth trends to see how these two distinct ETF strategies stack up for different investor goals.
Via The Motley Fool · June 7, 2026
Expense ratios remain among the lowest in the industry, while sector allocations and risk profiles differ sharply between these two core portfolio options.
Via The Motley Fool · June 5, 2026
Expense ratios, sector weightings, and five-year risk profiles reveal key differences between these popular growth ETFs. Which approach aligns with your goals?
Via The Motley Fool · May 26, 2026
Expense ratios, dividend yields, and portfolio concentration set these two Vanguard growth ETFs apart.
Via The Motley Fool · May 21, 2026
Artivion delivers advanced cardiovascular and vascular solutions to healthcare providers worldwide through its proprietary medical devices.
Via The Motley Fool · May 17, 2026
Expense ratios and sector exposure set these two growth ETFs apart, with recent performance and volatility revealing distinct investor trade-offs.
Via The Motley Fool · May 11, 2026
This tech-focused fund is not the best option.
Via The Motley Fool · May 10, 2026
